SCHEMBL24823

SCHEMBL24823

OCCC(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28989865 0.82 THRB (0.35)
SCHEMBL477956 0.77
SCHEMBL3458462 0.75
SCHEMBL578466 0.74
SCHEMBL11102876 0.72 LMNA (0.38)
SCHEMBL5416483 0.72 LMNA (0.38)
SCHEMBL11101915 0.72 LMNA (0.38)
SCHEMBL574847 0.72
SCHEMBL7858172 0.72 LMNA (0.38)
SCHEMBL1056238 0.72

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 982 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250323319-A1 FLUORINATED ELECTROLYTE ADDITIVES E3TRIGEN, INC. (US) 2025-10-16 US claimed
CN-113713795-B Composite oxide carrier and preparation method thereof 中国石油化工股份有限公司 2024-05-07 CN claimed
CN-113713835-B Hydrogenation catalyst based on composite oxide carrier and preparation method and application thereof 中国石油化工股份有限公司 2024-02-20 CN claimed
US-20230348421-A1 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF LUYE INNOMIND PHARMA SHIJIAZHUANG CO., LTD. (CN) 2023-11-02 US claimed
EP-4186893-A1 5-HT2A RECEPTOR INHIBITOR OR INVERSE AGONIST, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF Geneora Pharma (Shijiazhuang) Co., Ltd. (CN) 2023-05-31 EP claimed
WO-2022253700-A1 SPECIFICALLY SUBSTITUTED PYRROLINE-2-ONES AND THEIR USE AS HERBICIDES BAYER AKTIENGESELLSCHAFT (DE) 2022-12-08 WO claimed
US-20220384848-A1 FLUORINATED ELECTROLYTE ADDITIVES E3TRIGEN, INC. (US) 2022-12-01 US claimed
EP-4032138-A1 FLUORINATED ELECTROLYTE ADDITIVES E3Trigen, Inc. (US) 2022-07-27 EP claimed
CN-108218849-B Novel inhibitors 维沃永治疗公众有限公司 2022-03-01 CN claimed
CN-113713795-A Composite oxide carrier and preparation method thereof 中国石油化工股份有限公司 2021-11-30 CN claimed
US-20100056581-A1 Substituted Piperidino Phenyloxazolidinones PATEL MAHESH VITHALBHAI 2010-03-04 US claimed
EP-2018792-A2 SUBSTITUTED PIPERIDINO PHENYLOXAZOLIDINONES Wockhardt Limited (IN) 2009-01-28 EP claimed
US-7419620-B2 Dichroic mixtures ROLIC LTD C/O ROLIC TECHNOLOGIES LTD (CH) 2008-09-02 US claimed
EP-1385914-B1 DICHROIC MIXTURE ROLIC AG (CH) 2008-07-23 EP claimed
WO-2007132314-A2 SUBSTITUTED PIPERIDINO PHENYLOXAZOLIDINONES WOCKHARDT LTD (IN) 2007-11-22 WO claimed
US-20040164272-A1 Dichoric mixture ROLIC AG (CH) 2004-08-26 US claimed
EP-1385914-A1 DICHROIC MIXTURE Rolic AG (CH) 2004-02-04 EP claimed
WO-2002090447-A1 DICHROIC MIXTURE ROLIC AG (CH) 2002-11-14 WO claimed
EP-1256602-A1 Dichroic mixture Rolic AG (CH) 2002-11-13 EP claimed
EP-0153926-B2 MICRODROPLETS OF WATER-INSOLUBLE DRUGS PHARMA LOGIC INC (US) 1999-03-10 EP claimed